Bioextrax AB
The answer first
Does Bioextrax beat the market?
Yes, Bioextrax has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 62% of Nordic stocks
- Quality100
- Value2
- Trend71
No. 156 of 322 in industrials
Max for seven days
Follow Bioextrax with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Bioextrax
Your first answer is free, no account needed.
Do you own Bioextrax, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Bioextrax and a few more. Free, no card.
Super Stock+45.9%In short
- Bioextrax has risen 24.4% over the past year, including dividends.
- Overall, Bioextrax ranks better than 62% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 98.1%. The price is 97.2% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 62% of Nordic stocks.
No. 156 of 322 in industrials
High A solid company: it earns well on its money and has healthy finances.
No. 1 of 328 in industrialsTypical in industrials: 53Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity–
- Asset turnoverSales divided by everything the company owns0.04
- Return on equityProfit divided by equity−155.0%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 322 of 325 in industrialsTypical in industrials: 56Typical in the Nordics: 50
- P/BPrice divided by equity9.8
- P/SPrice divided by sales215.9
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 118 of 332 in industrialsTypical in industrials: 57Typical in the Nordics: 50
- 3 months+23.3%
- 6 months−6.7%
- 9 months−18.8%
- 12 months+24.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Bioextrax
2 funds we follow own Bioextrax. The share is how much of the fund the stock makes up.
- Sweden2
From the funds' latest known holdings.
About Bioextrax
Bioextrax AB is a company in industrials, listed on Nasdaq Stockholm. The share trades in SEK. It has around 14 employees.
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for composites, agriculture, filtration, padding, textiles, and more. Bioextrax AB (publ) was incorporated in 2014 and is based in Lund, Sweden.


See the full analysis of Bioextrax.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card